S&P Futures
5,954.25 -4.00 (-0.07%) Dow Futures
43,909.00 +8.00 (+0.02%) Nasdaq Futures
20,878.25 -15.75 (-0.08%) Russell 2000 Futures
2,402.30 -3.50 (-0.15%) Crude Oil
71.97 +0.28 (+0.39%) Gold
2,660.80 -15.50 (-0.58%)
Kyverna Therapeutics, Inc. (KYTX)
After hours:
| Previous Close | 5.09 |
| Open | 5.23 |
| Bid | 5.10 x 200 |
| Ask | 5.23 x 100 |
| Day's Range | 5.10 - 5.49 |
| 52 Week Range | 4.40 - 30.60 |
| Volume | |
| Avg. Volume | 383,707 |
| Market Cap | 221.344M |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -2.13 |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 30.40 |
PR NewswireKyverna Therapeutics Appoints Mert Aktar to its Board of Directors
Kyverna Therapeutics, Inc. (Kyverna), a patient-centered, clinical-stage biopharmaceutical company focused on developing cell therapies for patients suffering from autoimmune diseases, today announced the appointment of biotechnology executive and cell therapy veteran Mert Aktar as an independent director to its Board of Directors. Mr. Aktar has over two decades of biopharmaceutical experience, melding more than a decade of technical leadership in cell and gene therapy with a proven track record
Insider MonkeyKyverna Therapeutics (KYTX): Leading Nano Cap with Promising CAR T-Cell Therapy
We recently published a list of 7 Best Nano Cap Stocks To Invest In. In this article, we are going to take a look at where Kyverna Therapeutics, Inc. (NASDAQ:KYTX) stands against other best nano cap stocks to invest in. What Are the Small Cap Bulls Saying? In one of our recent articles about 8 Most […]
